Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Conditions

Breast Neoplasms 4354Neoplasms 3055Prostatic Neoplasms 1904Colorectal Neoplasms 1738Lung Neoplasms 1555Carcinoma, Non-Small-Cell Lung 1270Pancreatic Neoplasms 981Multiple Myeloma 951Leukemia, Myeloid, Acute 951Lymphoma 912Head and Neck Neoplasms 894Leukemia 852Precursor Cell Lymphoblastic Leukemia-Lymphoma 833Neoplasm Metastasis 793Colonic Neoplasms 785Carcinoma, Hepatocellular 762Ovarian Neoplasms 757Melanoma 752Stomach Neoplasms 740Rectal Neoplasms 701Brain Neoplasms 696Lymphoma, Non-Hodgkin 663Leukemia, Lymphocytic, Chronic, B-Cell 618Uterine Cervical Neoplasms 607Lymphoma, Follicular 559Glioblastoma 541Recurrence 539Hodgkin Disease 532Esophageal Neoplasms 527Myelodysplastic Syndromes 508

Interventions

Ranibizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Conjunctival Neoplasms × Clear all
NCT05645341 2024-08-05

Artificial Intelligence-assisted Screening of Malignant Pigmented Tumors on the Ocular Surface

Sun Yat-sen University

Completed
535 enrolled

Conjunctival Neoplasms, Eye Neoplasms, Orbital Neoplasms

NCT03515954 2019-01-02

AS-OCT Guided Treatment of Diffuse CSCC

Benha University

Completed
15 enrolled

Conjunctival Neoplasms

NCT00456495 2017-07-21

Effect of Ranibizumab on Malignant Conjunctival Neoplasia

The New York Eye Cancer Center

Phase 1 Completed
5 enrolled 6 charts

Conjunctival Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡